FIELD: medicine.
SUBSTANCE: invention refers to an antituberculosis drug containing sodium aminosalicylate 2.0-14.0 g and chlorine ions 0.00020-0.00150 g.
EFFECT: preparing the stable and effective antibuberculosis drug.
3 ex
| Title | Year | Author | Number |
|---|---|---|---|
| MEDICINE FOR TREATING TUBERCULOSIS | 2009 |
|
RU2487702C2 |
| MEDICATION FOR TUBERCULOSIS TREATMENT | 2009 |
|
RU2405554C1 |
| COMBINED ANTITUBERCULOUS COMPOSITION | 2009 |
|
RU2413517C1 |
| COMBINED ANTITUBERCULOUS COMPOSITION | 2010 |
|
RU2468802C2 |
| PHARMACEUTICAL ANTI-TUBERCULOSIS COMBINED COMPOSITION | 2009 |
|
RU2424808C2 |
| COMBINED ANTITUBERCULOUS PHARMACEUTICAL COMPOSITION | 2010 |
|
RU2436580C1 |
| ANTITUBERCULOUS DRUG AND METHOD OF TREATING | 2010 |
|
RU2449797C1 |
| ANTITUBERCULOUS PHARMACEUTICAL COMPOSITION FOR PARENTERAL USE IN SMALL DOSAGES VOLUME | 2014 |
|
RU2578433C1 |
| PHARMACEUTICAL COMPOSITION POSSESSING ANTIAGGREGANT ACTIVITY | 2019 |
|
RU2709017C1 |
| ANTITUBERCULOUS COMPOSITION AND METHOD FOR PREPARING IT | 2011 |
|
RU2472512C1 |
Authors
Dates
2012-11-20—Published
2009-05-12—Filed